{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:36:50Z","timestamp":1786628210687,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","award":["26UQU4420025GSSR01"],"award-info":[{"award-number":["26UQU4420025GSSR01"]}],"id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154156","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:25:22Z","timestamp":1781565922000},"page":"154156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Canadine (tetrahydroberberine) as a GyrB-Targeting antibacterial lead against Acinetobacter baumannii: Integrated phenotypic, computational, and enzymatic evidence"],"prefix":"10.1016","volume":"829","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-4563","authenticated-orcid":false,"given":"Ahlam","family":"Alasiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.bbrc.2026.154156_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154156_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the mechanisms of Acinetobacter baumannii virulence","volume":"16","author":"Harding","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154156_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub Moubareck","year":"2020","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154156_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154156_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/acsinfecdis.4c00128","article-title":"Gyrase and topoisomerase IV: recycling old targets for new antibacterials to combat fluoroquinolone resistance","volume":"10","author":"Collins","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"6328","key":"10.1016\/j.bbrc.2026.154156_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/351624a0","article-title":"Crystal structure of an N-terminal fragment of the DNA gyrase B protein","volume":"351","author":"Wigley","year":"1991","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154156_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154156_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154156_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106126","article-title":"Natural isoquinoline alkaloids: pharmacological features and multi-target potential for complex diseases","volume":"177","author":"Plazas","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154156_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1107\/S2053229615004076","article-title":"Tetrahydroberberine, a pharmacologically active naturally occurring alkaloid","volume":"71","author":"Pingali","year":"2015","journal-title":"Cryst. Struct. Commun."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154156_bib11","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1016\/j.bmc.2008.02.015","article-title":"Antioxidant and cytotoxic activities of canadine: biological effects and structural aspects","volume":"16","author":"Correch\u00e9","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154156_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-2001-16493","article-title":"Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids","volume":"67","author":"Scazzocchio","year":"2001","journal-title":"Planta Med."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154156_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1021\/np9701889","article-title":"Antitubercular natural products: berberine from the roots of commercial Hydrastis c anadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, \u03b2-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and-2","volume":"61","author":"Gentry","year":"1998","journal-title":"J. Nat. Prod."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154156_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-0030-1250606","article-title":"Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition","volume":"77","author":"Ettefagh","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2026.154156_bib15","article-title":"Berberine and its nanoformulations and extracts: potential strategies and future perspectives against multi-drug resistant bacterial infections","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.154156_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2018.01.038","article-title":"Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii","volume":"146","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154156_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097514","article-title":"Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154156_bib18","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/acs.jmedchem.2c01597","article-title":"Discovery and hit-to-lead optimization of benzothiazole scaffold-based DNA gyrase inhibitors with potent activity against Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"66","author":"Cotman","year":"2023","journal-title":"J. Med. Chem."},{"issue":"D1","key":"10.1016\/j.bbrc.2026.154156_bib19","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.bbrc.2026.154156_bib20","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154156_bib21","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2. 0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154156_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154156_bib23","series-title":"CHARMM\u2010GUI Ligand Reader and Modeler for CHARMM Force Field Generation of Small Molecules","author":"Kim","year":"2017"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154156_bib24","doi-asserted-by":"crossref","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154156_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154156_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"32","key":"10.1016\/j.bbrc.2026.154156_bib27","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/bi970294+","article-title":"The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study","volume":"36","author":"Holdgate","year":"1997","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.bbrc.2026.154156_bib28","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154156_bib29","series-title":"Susceptibility Test Methods: Dilution and Disk Diffusion Methods","first-page":"1122","author":"Patel","year":"2011"},{"key":"10.1016\/j.bbrc.2026.154156_bib30","series-title":"Global Research Agenda for Antimicrobial Resistance in Human Health","year":"2024"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:00:37Z","timestamp":1786626037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26009204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0006291X26009204"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154156","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadine (tetrahydroberberine) as a GyrB-Targeting antibacterial lead against Acinetobacter baumannii: Integrated phenotypic, computational, and enzymatic evidence","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154156"}}